Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Antibiotic | Research

Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis

Authors: Jessica Vandenhaute, Elyonore Tsakeu, Pierre Chevalier, Manjiri Pawaskar, Goran Benčina, Jan Vertriest

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Varicella is a highly contagious infection that typically occurs in childhood. While most cases have a generally benign outcome, infection results in a considerable healthcare burden and serious complications may occur.

Objectives

The objective of this study was to characterize the burden of varicella in a real-world primary care setting in Belgium, including the rate of varicella-related complications, medication management and general practitioner (GP) visits.

Methods

The study was a retrospective observational study using data from a longitudinal patient database in a primary care setting in Belgium. Patients with a GP visit and a varicella diagnosis between January 2016 and June 2019 were eligible and data one month prior and three months after the diagnosis were included. Outcomes included varicella-related complications, antibiotic use, antiviral use, and GP follow-up visits. Antibiotic use could be specified by class of antibiotic and linked to a diagnosis. Complications were identified based on concomitant diagnosis with varicella during the study period.

Results

3,847 patients with diagnosis of varicella were included, with a mean age of 8.4 years and a comparable distribution of gender. 12.6% of patients with varicella had a concomitant diagnosis of a varicella-related complication. During the follow-up period, 27.3% of patients with varicella were prescribed antibiotics, either systemic (19.8%) and/or topical (10.3%). The highest rate of antibiotic prescriptions was observed in patients with complications (63.5%) and in patients younger than 1 year (41.8%). Nevertheless, 5.3% of the patients were prescribed antibiotics without a concomitant diagnosis of another infection. The most commonly prescribed systemic antibiotics were amoxicillin alone or combined with beta-lactamase inhibitor, and thiamphenicol. Fusidic acid and tobramycin were the most prescribed topical antibiotics. Antivirals were prescribed for 2.7% of the study population. 4.7% of the patients needed a follow-up visit with their GP.

Conclusions

This study reports a substantial burden of varicella in a primary care setting in Belgium, with high rates of complications and antibiotic use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gabutti G, Bolognesi N, Sandri F, Florescu C, Stefanati A. Varicella zoster virus vaccines: an update. Immunotargets Ther. 2019;8:15–28.CrossRef Gabutti G, Bolognesi N, Sandri F, Florescu C, Stefanati A. Varicella zoster virus vaccines: an update. Immunotargets Ther. 2019;8:15–28.CrossRef
2.
go back to reference Wutzler P, Casabona G, Cnops J, Akpo EIH, Safadi MAP. Herpes zoster in the context of varicella vaccination—an equation with several variables. Vaccine. 2018;36(46):7072–82.CrossRef Wutzler P, Casabona G, Cnops J, Akpo EIH, Safadi MAP. Herpes zoster in the context of varicella vaccination—an equation with several variables. Vaccine. 2018;36(46):7072–82.CrossRef
3.
go back to reference Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288–90.CrossRef Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288–90.CrossRef
4.
go back to reference Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing universal varicella vaccination in europe: the path forward. Pediatr Infect Dis J. 2019;38(2):181–8.CrossRef Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing universal varicella vaccination in europe: the path forward. Pediatr Infect Dis J. 2019;38(2):181–8.CrossRef
5.
go back to reference Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W: The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991–2016. Clin Infect Dis. 2019. Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W: The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991–2016. Clin Infect Dis. 2019.
6.
7.
go back to reference Forbes H, Douglas I, Finn A, Breuer J, Bhaskaran K, Smeeth L, Packer S, Langan S, Mansfield K, Marlow R, et al. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data. BMJ (Clinical research ed) 2020;368. Forbes H, Douglas I, Finn A, Breuer J, Bhaskaran K, Smeeth L, Packer S, Langan S, Mansfield K, Marlow R, et al. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data. BMJ (Clinical research ed) 2020;368.
8.
go back to reference Harpaz R, van Hoek A. Point-counterpoint: the Hope-Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence. J Infect Dis. 2018;218(Suppl_2):57.CrossRef Harpaz R, van Hoek A. Point-counterpoint: the Hope-Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence. J Infect Dis. 2018;218(Suppl_2):57.CrossRef
9.
go back to reference Talbird S, La E, Mauskopf J, Altland A, Daniels V, Wolfson L. Understanding the role of exogenous boosting in modeling varicella vaccination. Expert Rev Vac. 2018;17(11):1021–35.CrossRef Talbird S, La E, Mauskopf J, Altland A, Daniels V, Wolfson L. Understanding the role of exogenous boosting in modeling varicella vaccination. Expert Rev Vac. 2018;17(11):1021–35.CrossRef
10.
go back to reference Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure management and prophylaxis: a review. Prev Med Rep. 2019;16:101016.CrossRef Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure management and prophylaxis: a review. Prev Med Rep. 2019;16:101016.CrossRef
11.
go back to reference Hagemann C, Kramer A, Grote V, Liese JG, Streng A. Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a Multicenter Pediatric Hospital Surveillance Study in Bavaria (Germany). Infect Dis Ther. 2019;8(4):597–611.CrossRef Hagemann C, Kramer A, Grote V, Liese JG, Streng A. Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a Multicenter Pediatric Hospital Surveillance Study in Bavaria (Germany). Infect Dis Ther. 2019;8(4):597–611.CrossRef
12.
go back to reference Blumental S, Sabbe M, Lepage P. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016;101(1):16–22.CrossRef Blumental S, Sabbe M, Lepage P. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016;101(1):16–22.CrossRef
13.
go back to reference Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, et al. Varicella vaccination in Europe—taking the practical approach. BMC Med. 2009;7(1):1–12.CrossRef Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, et al. Varicella vaccination in Europe—taking the practical approach. BMC Med. 2009;7(1):1–12.CrossRef
14.
go back to reference Blumental S. Varicella in Belgium: results of a 1-year National survey year National survey and discussion on vaccination. In: 2019; ISP-WIV; 2019. Blumental S. Varicella in Belgium: results of a 1-year National survey year National survey and discussion on vaccination. In: 2019; ISP-WIV; 2019.
15.
go back to reference Sabbe M, Vanthomme K, Top G, Van Casteren V. Epidemiologie van windpokken en zona vastgesteld door huisartsen: 2006–2010. Vlaams Infect Bull. 2012. Sabbe M, Vanthomme K, Top G, Van Casteren V. Epidemiologie van windpokken en zona vastgesteld door huisartsen: 2006–2010. Vlaams Infect Bull. 2012.
16.
go back to reference Wysocki J, Malecka I, Stryczynska-Kazubska J, Rampakakis E, Kuter B, Wolfson LJ. Varicella in Poland: economic burden in children 1–12 years of age in Poland, 2010–2015. BMC Public Health 2018;18. Wysocki J, Malecka I, Stryczynska-Kazubska J, Rampakakis E, Kuter B, Wolfson LJ. Varicella in Poland: economic burden in children 1–12 years of age in Poland, 2010–2015. BMC Public Health 2018;18.
17.
go back to reference Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vac. 2008;7(6):753–82.CrossRef Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vac. 2008;7(6):753–82.CrossRef
18.
go back to reference Bruyndonckx R, Coenen S, Hens N, Vandael E, Catry B, Goossens H. Antibiotic use and resistance in Belgium: the impact of two decades of multi-faceted campaigning. Acta Clin Belg. 2020;76:280–8.CrossRef Bruyndonckx R, Coenen S, Hens N, Vandael E, Catry B, Goossens H. Antibiotic use and resistance in Belgium: the impact of two decades of multi-faceted campaigning. Acta Clin Belg. 2020;76:280–8.CrossRef
19.
go back to reference Ebell MH, Radke T. Antibiotic use for viral acute respiratory tract infections remains common. Am J Manag Care. 2015;21(10):e567-575.PubMed Ebell MH, Radke T. Antibiotic use for viral acute respiratory tract infections remains common. Am J Manag Care. 2015;21(10):e567-575.PubMed
20.
go back to reference Wolfson LJ, Castillo ME, Giglio N, Mészner Z, Molnár Z, Vàzquez M, Wysocki J, Altland A, Kuter BJ, Stutz M, et al. The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe. BMC Public Health. 2019;19(1):1–11.CrossRef Wolfson LJ, Castillo ME, Giglio N, Mészner Z, Molnár Z, Vàzquez M, Wysocki J, Altland A, Kuter BJ, Stutz M, et al. The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe. BMC Public Health. 2019;19(1):1–11.CrossRef
21.
go back to reference Levi M, Rosselli M, Simonetti M, Brignoli O, Cancian M, Masotti A, Pegoraro V, Cataldo N, Heiman F, Chelo M, et al. Epidemiology of iron deficiency anaemia in four european countries: a population-based study in primary care. Eur J Haematol. 2016;97(6):583–93.CrossRef Levi M, Rosselli M, Simonetti M, Brignoli O, Cancian M, Masotti A, Pegoraro V, Cataldo N, Heiman F, Chelo M, et al. Epidemiology of iron deficiency anaemia in four european countries: a population-based study in primary care. Eur J Haematol. 2016;97(6):583–93.CrossRef
22.
go back to reference Levi M, Simonetti M, Marconi E, Brignoli O, Cancian M, Masotti A, Pegoraro V, Heiman F, Cricelli C, Lapi F. Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries. Ann Hematol. 2019;98(7):1573–82.CrossRef Levi M, Simonetti M, Marconi E, Brignoli O, Cancian M, Masotti A, Pegoraro V, Heiman F, Cricelli C, Lapi F. Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries. Ann Hematol. 2019;98(7):1573–82.CrossRef
23.
go back to reference Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi J, Van Bruwaene S. Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study. Int J Antimicrob Agents. 2020;56:105966.CrossRef Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi J, Van Bruwaene S. Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study. Int J Antimicrob Agents. 2020;56:105966.CrossRef
24.
go back to reference European Centre for Disease Prevention Control. Antimicrobial consumption in the EU/EEA-Annual epidemiological report for 2019. In.: ECDC Stockholm; 2020. European Centre for Disease Prevention Control. Antimicrobial consumption in the EU/EEA-Annual epidemiological report for 2019. In.: ECDC Stockholm; 2020.
25.
go back to reference Belgian Antibiotic Policy Coordination Committee: Guide belge des traitements anti-infectieux en pratique ambulatoire. In. Edited by Health fcsae, vol. 2020, 2019 edn: Centre belge d'information pharmacothérapeutique; 2019. Belgian Antibiotic Policy Coordination Committee: Guide belge des traitements anti-infectieux en pratique ambulatoire. In. Edited by Health fcsae, vol. 2020, 2019 edn: Centre belge d'information pharmacothérapeutique; 2019.
26.
go back to reference Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy: experiences from eight Italian Regions. Hum Vac Immunother. 2015;11:63–71.CrossRef Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy: experiences from eight Italian Regions. Hum Vac Immunother. 2015;11:63–71.CrossRef
27.
go back to reference Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, Greiner W. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016;61:847–60.CrossRef Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, Greiner W. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016;61:847–60.CrossRef
28.
go back to reference Johannes GL, Cohen C, Rack A, Pirzer K, Eber S, Blum M, Greenberg M, Streng A. The effectiveness of varicella vaccination in children in Germany: a case–control study. Pediatr Infect Dis J. 2013;32(9):998–1004.CrossRef Johannes GL, Cohen C, Rack A, Pirzer K, Eber S, Blum M, Greenberg M, Streng A. The effectiveness of varicella vaccination in children in Germany: a case–control study. Pediatr Infect Dis J. 2013;32(9):998–1004.CrossRef
29.
go back to reference Pawaskar M, Burgess C, Pillsbury M, Wisloff T, Flem E. Clinical and economic impact of universal varicella vaccination in Norway: a modeling study. PLoS ONE. 2021;16(7):e0254080.CrossRef Pawaskar M, Burgess C, Pillsbury M, Wisloff T, Flem E. Clinical and economic impact of universal varicella vaccination in Norway: a modeling study. PLoS ONE. 2021;16(7):e0254080.CrossRef
30.
go back to reference Wutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, Casabona G. Varicella vaccination—the global experience. Expert Rev Vac. 2017;16(8):833–43.CrossRef Wutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, Casabona G. Varicella vaccination—the global experience. Expert Rev Vac. 2017;16(8):833–43.CrossRef
31.
go back to reference FAMHP, BACB. Leidraad over niet-interventionele studies. In. Brussels: Federal Agency for Medicines and Health Products & Belgian Advisory Committee on Bioethics; 2008. FAMHP, BACB. Leidraad over niet-interventionele studies. In. Brussels: Federal Agency for Medicines and Health Products & Belgian Advisory Committee on Bioethics; 2008.
Metadata
Title
Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis
Authors
Jessica Vandenhaute
Elyonore Tsakeu
Pierre Chevalier
Manjiri Pawaskar
Goran Benčina
Jan Vertriest
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
Antibiotic
Care
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06848-4

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.